Scholarlink

Late-life depression (LLD) is a prevalent and debilitating disease closely associated with cognitive decline, exacerbation of chronic medical illness, decreased quality of life, and increased societal burden. This review explores the complex neurobiological mechanisms and key risk factors underlying LLD. Inflammation, particularly involving cytokines such as IL-6 and TNF-α and the activation of the NLRP3 inflammasome, plays a central role. Genetic vulnerability, including polymorphisms in serotonin-transporter-linked polymorphic region (5-HTTLPR), BDNF Val66Met, and methylenetetrahydrofolate reductase (MTHFR), interacts with environmental stressors to increase susceptibility. Dysregulation of neurotransmitters such as serotonin, dopamine, norepinephrine, glutamate, and GABA contributes to core depressive symptoms. LLD is also characterized by functional disruptions in large-scale brain networks and structural changes including cortical thinning and hippocampal atrophy. Additionally, HPA (hypothalamic–pituitary–adrenal) axis hyperactivity, gut microbiota dysbiosis, and metabolic disorders such as hypertension and diabetes further exacerbate LLD. LLD is a multifactorial disorder involving complex interactions among neurobiological systems. Effective prevention and management require an integrated, multidisciplinary approach that considers inflammation, genetics, neurotransmission, and brain structure alterations.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Complex Neurobiological Mechanisms and Risk Factors Underlying Late-Life Depression

  • 章节

  • 发表日期：

    2026年

查看全文
  • Kang Joon Lee,
  • Yong-Ku Kim

摘要

Late-life depression (LLD) is a prevalent and debilitating disease closely associated with cognitive decline, exacerbation of chronic medical illness, decreased quality of life, and increased societal burden. This review explores the complex neurobiological mechanisms and key risk factors underlying LLD. Inflammation, particularly involving cytokines such as IL-6 and TNF-α and the activation of the NLRP3 inflammasome, plays a central role. Genetic vulnerability, including polymorphisms in serotonin-transporter-linked polymorphic region (5-HTTLPR), BDNF Val66Met, and methylenetetrahydrofolate reductase (MTHFR), interacts with environmental stressors to increase susceptibility. Dysregulation of neurotransmitters such as serotonin, dopamine, norepinephrine, glutamate, and GABA contributes to core depressive symptoms. LLD is also characterized by functional disruptions in large-scale brain networks and structural changes including cortical thinning and hippocampal atrophy. Additionally, HPA (hypothalamic–pituitary–adrenal) axis hyperactivity, gut microbiota dysbiosis, and metabolic disorders such as hypertension and diabetes further exacerbate LLD. LLD is a multifactorial disorder involving complex interactions among neurobiological systems. Effective prevention and management require an integrated, multidisciplinary approach that considers inflammation, genetics, neurotransmission, and brain structure alterations.